Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
about
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor.The novel C24D synthetic polypeptide inhibits binding of placenta immunosuppressive ferritin to human T cells and elicits anti-breast cancer immunity in vitro and in vivo.In vitro and in vivo model of a novel immunotherapy approach for chronic lymphocytic leukemia by anti-CD23 chimeric antigen receptor.Cytolytic and cytotoxic activity of a human natural killer cell line genetically modified to specifically recognize HER-2/neu overexpressing tumor cells.
P2860
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
@ast
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
@en
type
label
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
@ast
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
@en
prefLabel
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
@ast
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
@en
P1476
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
@en
P2093
Constantin N Baxevanis
Michael Papamichail
P2888
P304
P356
10.1007/S00262-004-0523-Y
P577
2004-05-26T00:00:00Z